ATHIRA PHARMA INC (ATHA) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:ATHA • US04746L2034

6.75 USD
-0.44 (-6.12%)
At close: Jan 9, 2026
6.9496 USD
+0.2 (+2.96%)
After Hours: 1/9/2026, 8:00:00 PM
Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to ATHA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 4.08. This target is -39.56% below the current price.
  • ATHA was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about ATHA.
  • In the previous month the buy percentage consensus was at a similar level.
  • ATHA was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

ATHA Historical Analyst RatingsATHA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -63 -57 -51 -45 -39 -33 -27 -21 -15 -9 -3 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 6.754.044.084.084.20 - -40.15% -39.56% -39.56% -37.78%

Related screens

ATHA Current Analyst RatingATHA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-09-19 Mizuho Downgrade Outperform -> Neutral
2024-09-04 BTIG Downgrade Buy -> Neutral
2024-09-04 JMP Securities Downgrade Market Outperform -> Market Perform
2024-08-19 Rodman & Renshaw Initiate Buy
2024-06-20 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-05-16 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-08-11 JMP Securities Maintains Outperform -> Outperform
2023-05-15 Mizuho Maintains Buy -> Buy
2023-03-30 BTIG Maintains Buy
2023-03-24 JMP Securities Reiterate Market Outperform
2022-07-07 Mizuho Initiate Buy
2022-06-23 JMP Securities Downgrade Market Outperform -> Market Perform
2022-06-23 Stifel Downgrade Buy -> Hold
2022-06-23 Jefferies Downgrade Buy -> Hold
2022-05-10 BTIG Initiate Buy
2022-04-21 Berenberg Initiate Buy
2021-12-15 Goldman Sachs Initiate Neutral

ATHIRA PHARMA INC / ATHA FAQ

What is the price target for ATHA stock?

7 analysts have analysed ATHA and the average price target is 4.08 USD. This implies a price decrease of -39.56% is expected in the next year compared to the current price of 6.75.


How do analysts rate ATHIRA PHARMA INC (ATHA)?

The consensus rating for ATHIRA PHARMA INC (ATHA) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.